Cargando…

An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias

Lewy body dementias are the second most common cause of neurodegenerative dementia in the elderly after Alzheimer’s disease (AD). The two clinical subgroups of Lewy body dementias, namely, dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), are differentiated by the chronology of...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Arnab, Chai, Yuek Ling, Tan, Jing Min, Lee, Jasinda H., Francis, Paul T., Chen, Christopher P., Sze, Siu Kwan, Lai, Mitchell K. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553757/
https://www.ncbi.nlm.nih.gov/pubmed/28800743
http://dx.doi.org/10.1186/s13041-017-0316-9
_version_ 1783256669432578048
author Datta, Arnab
Chai, Yuek Ling
Tan, Jing Min
Lee, Jasinda H.
Francis, Paul T.
Chen, Christopher P.
Sze, Siu Kwan
Lai, Mitchell K. P.
author_facet Datta, Arnab
Chai, Yuek Ling
Tan, Jing Min
Lee, Jasinda H.
Francis, Paul T.
Chen, Christopher P.
Sze, Siu Kwan
Lai, Mitchell K. P.
author_sort Datta, Arnab
collection PubMed
description Lewy body dementias are the second most common cause of neurodegenerative dementia in the elderly after Alzheimer’s disease (AD). The two clinical subgroups of Lewy body dementias, namely, dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), are differentiated by the chronology of cognitive symptoms relative to parkinsonism. At present, there remains a debate on whether DLB and PDD are separate disease entities, or fall within the same spectrum of Lewy body dementias. In this study, we compared the detergent-soluble proteome via an 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) analysis of pooled lysates from the prefrontal cortex (BA9) of DLB (n = 19) and PDD (n = 21) patients matched a priori for amyloid (total Aβ42) burden, semi-quantitative scores for Lewy bodies and neurofibrillary tangles together with age-matched control (n = 21) subjects. A total of 1914 proteins were confidently identified by iTRAQ (false discovery rate = 0%). None of the proteins showed a significant yet opposite regulation in between DLB and PDD when compared to aged controls in the proteomic data set as well as following immunoblot analysis of the pooled and individual lysates involving all 61 subjects. The postsynaptic protein, synaptopodin (SYNPO) was significantly down-regulated in both DLB and PDD subgroups, suggesting a defective synaptic transmission in the demented patients. In conclusion, the largely similar proteome of DLB and PDD matched for amyloid burden suggests that variations in concomitant AD-related pathology, abnormal post-translational modifications or protein-protein interactions, defective intracellular trafficking or misfolding of proteins could play a part in driving the clinically observed differences between these two subgroups of Lewy body dementias. This further indicates that amyloid-targeting therapeutic strategies may show different efficacies in DLB versus PDD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13041-017-0316-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5553757
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55537572017-08-15 An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias Datta, Arnab Chai, Yuek Ling Tan, Jing Min Lee, Jasinda H. Francis, Paul T. Chen, Christopher P. Sze, Siu Kwan Lai, Mitchell K. P. Mol Brain Research Lewy body dementias are the second most common cause of neurodegenerative dementia in the elderly after Alzheimer’s disease (AD). The two clinical subgroups of Lewy body dementias, namely, dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD), are differentiated by the chronology of cognitive symptoms relative to parkinsonism. At present, there remains a debate on whether DLB and PDD are separate disease entities, or fall within the same spectrum of Lewy body dementias. In this study, we compared the detergent-soluble proteome via an 8-plex isobaric tag for relative and absolute quantitation (iTRAQ) analysis of pooled lysates from the prefrontal cortex (BA9) of DLB (n = 19) and PDD (n = 21) patients matched a priori for amyloid (total Aβ42) burden, semi-quantitative scores for Lewy bodies and neurofibrillary tangles together with age-matched control (n = 21) subjects. A total of 1914 proteins were confidently identified by iTRAQ (false discovery rate = 0%). None of the proteins showed a significant yet opposite regulation in between DLB and PDD when compared to aged controls in the proteomic data set as well as following immunoblot analysis of the pooled and individual lysates involving all 61 subjects. The postsynaptic protein, synaptopodin (SYNPO) was significantly down-regulated in both DLB and PDD subgroups, suggesting a defective synaptic transmission in the demented patients. In conclusion, the largely similar proteome of DLB and PDD matched for amyloid burden suggests that variations in concomitant AD-related pathology, abnormal post-translational modifications or protein-protein interactions, defective intracellular trafficking or misfolding of proteins could play a part in driving the clinically observed differences between these two subgroups of Lewy body dementias. This further indicates that amyloid-targeting therapeutic strategies may show different efficacies in DLB versus PDD. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13041-017-0316-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-11 /pmc/articles/PMC5553757/ /pubmed/28800743 http://dx.doi.org/10.1186/s13041-017-0316-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Datta, Arnab
Chai, Yuek Ling
Tan, Jing Min
Lee, Jasinda H.
Francis, Paul T.
Chen, Christopher P.
Sze, Siu Kwan
Lai, Mitchell K. P.
An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title_full An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title_fullStr An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title_full_unstemmed An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title_short An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementias
title_sort itraq-based proteomic analysis reveals dysregulation of neocortical synaptopodin in lewy body dementias
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553757/
https://www.ncbi.nlm.nih.gov/pubmed/28800743
http://dx.doi.org/10.1186/s13041-017-0316-9
work_keys_str_mv AT dattaarnab anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT chaiyuekling anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT tanjingmin anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT leejasindah anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT francispault anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT chenchristopherp anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT szesiukwan anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT laimitchellkp anitraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT dattaarnab itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT chaiyuekling itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT tanjingmin itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT leejasindah itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT francispault itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT chenchristopherp itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT szesiukwan itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias
AT laimitchellkp itraqbasedproteomicanalysisrevealsdysregulationofneocorticalsynaptopodininlewybodydementias